23 Nov 2017 | 4:38 PM
Research Report

Equity Research Report: Religare Morning Digest

Though activities usually dry up across the global markets around New Year but due to derivative expiry next week, traders will continue to see significant move on local front.
28 Dec 2015 | 07:00 AM

Aurobindo Pharma Ltd has received final approval from the US health regulator to manufacture and market Famotidine Tablets used for acid reflux treatment.

Vivimed Labs said the Competition Commission has given its approval for a deal with Clariant Chemicals India to sell some of the products in its speciality chemicals division.

Biocon has introduced a novel therapy CIMIVIR-L for the treatment of Hepatitis C patients in India.